Insurers typically require documentation of inadequate glycemic control despite metformin therapy, contraindications to other agents, or presence of specific comorbidities that make GLP-1 therapy medically necessary
If gastrointestinal symptoms are problematic, your provider may recommend delaying dose increases, temporarily reducing your dose, or holding treatment briefly while symptoms improve
The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
Understanding what to expect during this initial period helps patients navigate the adjustment phase successfully
The response wasnt the roaring thunder Id feared, but a muted Oh, good for you. Seeing there wasnt a backlash, I then started telling anyone who complimented me on my new physique, even if they didnt ask how I got it, that I was using a GLP-1